Pulmonary Research of Abingdon, LLC

Country

Ownership: Private

Employees: -

Market Cap: -

Website

Clinical Trials

Examination of Pirfenidone (Esbriet®) Therapy in Coal Workers' Pneumoconiosis With Pulmonary Fibrosis

Phase 2

Completed

Conditions: Coal Workers' Pneumoconiosis (Complicated)

Interventions: Drug: Pirfenidone

First Posted Date: 2020-07-08

Last Posted Date: 2024-07-16

Lead Sponsor: Pulmonary Research of Abingdon, LLC

Target Recruit Count: 50

Registration Number: NCT04461587

Locations: 🇺🇸
Pulmonary Research of Abingdon, LLC, Abingdon, Virginia, United States

Prev
1
Next

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy